Neuronetics, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-39.0M | $-43.7M | $-30.2M | $-37.2M | $-31.2M | $-27.5M | $-29.0M | $-24.1M |
| Depreciation & Amortization | $3.5M | $2.1M | $2.0M | $1.6M | $1.1M | $941.0K | $1.1M | $882.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $1.5M | $100.0K | — | — | — | — | — | — |
| Stock-Based Compensation | $6.8M | $5.6M | $7.3M | $8.7M | $7.9M | $4.4M | $3.4M | $1.7M |
| Net Cash from Operating Activities | $-20.4M | $-31.0M | $-32.0M | $-30.7M | $-28.0M | $-28.4M | $-30.5M | $-20.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $801.0K | $1.5M | $2.4M | $3.3M | $2.4M | $730.0K | $813.0K | $1.0M |
| Business Acquisitions | — | $2.6M | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-801.0K | $-2.4M | $-1.3M | $6.7M | $-9.8M | $-730.0K | $-813.0K | $-1.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $35.9M | $-6.8M | $22.7M | $207.0K | $83.0M | $2.4M | $2.4M | $97.0M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-21.2M | $-32.5M | $-34.4M | $-34.0M | $-30.3M | $-29.1M | $-31.3M | $-21.6M |